<?xml version="1.0" encoding="UTF-8"?>

<rootTag>
  <Award>
    <AwardTitle>I-Corps: High Quality Boron Nitride Nanotubes</AwardTitle>
    <AwardEffectiveDate>10/01/2012</AwardEffectiveDate>
    <AwardExpirationDate>09/30/2013</AwardExpirationDate>
    <AwardAmount>50000</AwardAmount>
    <AwardInstrument>
      <Value>Standard Grant</Value>
    </AwardInstrument>
    <Organization>
      <Code>07070000</Code>
      <Directorate>
        <LongName>Directorate For Engineering</LongName>
      </Directorate>
      <Division>
        <LongName>Div Of Industrial Innovation &amp; Partnersh</LongName>
      </Division>
    </Organization>
    <ProgramOfficer>
      <SignBlockName>Rathindra DasGupta</SignBlockName>
    </ProgramOfficer>
    <AbstractNarration>Boron nitride nanotubes (BNNTs) are structurally similar to carbon nanotubes (CNTs) with many similar properties such as extraordinarily high mechanical strength and thermal conductivity. Unlike CNTs, BNNTs have a uniform band gap (~5.5 eV) that is not sensitive to structural variations. Furthermore BNNTs are chemically more inert than CNTs, and have a higher resistance to oxidation at high temperatures. However, there are few research groups in the world capable of producing high-quality BNNTs. Based on their unique capability in growing high-quality BNNTs researchers will investigate a scanning chemical vapor deposition (SCVD) technique. Preliminary tests of the small SCVD system have demonstrated a 10-fold higher production yield of BNNTs. The yield could potentially be further improved by 1000-fold with the use of a bigger CVD system. &lt;br/&gt;&lt;br/&gt;If successfully completed, this project may further the use of BNNTs in various branches of science and engineering, including 1) insulating heat sink materials for high-performance electronic devices and engines, 2) doped BNNTs for nanoelectronic and photonic devices without the need of post-synthesis sorting, 3) chemically inert and high performance ceramics/alloys/composites, 4) boron neutron capture therapy (BNCT) for cancer treatment, 5) drug delivery using BNNTs.</AbstractNarration>
    <MinAmdLetterDate>10/23/2012</MinAmdLetterDate>
    <MaxAmdLetterDate>10/23/2012</MaxAmdLetterDate>
    <ARRAAmount/>
    <AwardID>1265116</AwardID>
    <Investigator>
      <FirstName>Yoke Khin</FirstName>
      <LastName>Yap</LastName>
      <EmailAddress>ykyap@mtu.edu</EmailAddress>
      <StartDate>10/23/2012</StartDate>
      <EndDate/>
      <RoleCode>Principal Investigator</RoleCode>
    </Investigator>
    <Investigator>
      <FirstName>Dustin</FirstName>
      <LastName>Winslow</LastName>
      <EmailAddress>dwinslow@mtu.edu</EmailAddress>
      <StartDate>10/23/2012</StartDate>
      <EndDate/>
      <RoleCode>Co-Principal Investigator</RoleCode>
    </Investigator>
    <Investigator>
      <FirstName>John</FirstName>
      <LastName>Diebel</LastName>
      <EmailAddress>jfdiebel@mtu.edu</EmailAddress>
      <StartDate>10/23/2012</StartDate>
      <EndDate/>
      <RoleCode>Co-Principal Investigator</RoleCode>
    </Investigator>
    <Institution>
      <Name>Michigan Technological University</Name>
      <CityName>Houghton</CityName>
      <ZipCode>499311295</ZipCode>
      <PhoneNumber>9064871885</PhoneNumber>
      <StreetAddress>1400 Townsend Drive</StreetAddress>
      <CountryName>United States</CountryName>
      <StateName>Michigan</StateName>
      <StateCode>MI</StateCode>
    </Institution>
  </Award>
</rootTag>
